Literature DB >> 941209

Serum-derived immunosuppressive substances. I. Partial purification and range of action.

F Miller.   

Abstract

Two alpha-globulin fractions which had in vivo and in vitro immunosuppressive activity were prepared from human serum. The larger fraction eluted from a molecular sieving gel in the albumin fraction and was heat labile whereas the smaller one was present in the elute fraction containing materials of 8,000-25,000 daltons and was heat stable. It is believed that the smaller of the two fractions is the immunoregulatory alpha-globulin described by several other investigators. The comparative activities of various starting materials and of partially purified derivatives in several systems (in vivo and in vitro) were examined. The possibility that these substances are lymphocytic chalones is considered.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 941209     DOI: 10.1097/00007890-197603000-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Interactions of alpha1-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness.

Authors:  K M Chiu; R F Mortensen; A P Osmand; H Gewurz
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

2.  Further purification and chemical characterization of the lymphocyte-inhibiting-factor extracted from thymus (LIFT).

Authors:  N Kiger; I Florentin; G Lorans; G Mathe
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

3.  Relationship between a spleen-derived immunosuppressive peptide 'SDIP' and the 'Facteur thymique sérique' (FTS): biochemical and biological comparison of the two factors.

Authors:  M Lenfant; L Millerioux; I Blazsek; N Duchange
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

Review 4.  Autoantibodies and serum inhibition factors (sif) in patients with myocarditis.

Authors:  B Maisch; P A Berg; K Kochsiek
Journal:  Klin Wochenschr       Date:  1980-03-03

5.  Detection of an inhibitor of cell division in cultures of tumour cells with immunosuppressive activity in vitro.

Authors:  J Werkmeister; R Zbroja; W McCarthy; P Hersey
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

6.  Presence of a tumour-inhibiting factor (TIF) in sera from normal but not tumour-bearing mice.

Authors:  B S Kim; D K Chin
Journal:  Immunology       Date:  1980-10       Impact factor: 7.397

7.  Identification and characterization of a tumor-derived immunosuppressive glycoprotein from murine melanoma K-1735.

Authors:  J B Putnam; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  Studies with a human plasma-derived immunosuppressive, anti-lymphoma factor.

Authors:  J L Farmer; M D Prager
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

9.  Characterization and purification of an immunosuppressive factor produced by a small cell lung cancer cell line.

Authors:  T Ikeda; T Masuno; T Ogura; M Watanabe; T Shirasaka; H Hara; Y Tanio; I Kawase; S Kishimoto
Journal:  Jpn J Cancer Res       Date:  1991-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.